Biopharma Logistics: Specialized Solutions for Biotech

Key Takeaways

• Many biologics need tighter temperature control than standard medicines.
• Many cell and gene therapies ship cryogenically, at -150°C or colder.
• Personalized therapies need a chain of identity to reach the right patient.
• The right 3PL partner scales biopharma logistics from trials to launch.

Biologics are the cutting edge of medicine, bringing dramatic improvements in quality of life and health for patients. But they can be fragile and degrade quickly. Transporting biotech treatments at scale to hospitals requires extra care in biopharma logistics to prevent losses and ensure that personalized medicines make it to the right patients.

What Makes Biopharma Logistics Different?

Many biologics, and especially cell and gene therapies, need tighter temperature control than standard medicines, and some must stay frozen, ultra-cold, or cryogenic in transit. In-depth monitoring is needed to prevent temperature variations that can damage costly products.

Biologics, Cell and Gene Therapies, and Specialty Handling Requirements

The products shipped through the biopharma logistics chain represent a high-value investment for manufacturers and patients. Losing limited cell lines and biologics that take significant time to produce can be financially devastating. Losses of personalized medicine also delay much-needed patient treatment and can result in worsening patient outcomes.

Specialized handling requirements are needed to protect temperature-sensitive and time-sensitive medicines during shipment. This helps ensure that fragile biologics, cells, and gene therapies arrive at a destination in good condition.

Why Standard Cold Chain Isn't Always Enough

The standard cold chain was developed primarily for traditional medicines and vaccines, the range our guide to pharma cold chain logistics covers in detail. Cell and gene therapies, some mRNA vaccines, and certain other biologics require frozen or deeper-cold storage that goes beyond what standard refrigeration provides.

A combination of unique protein structures and temperature-sensitive ingredients means many of these medicines can break down quickly outside their validated temperature range. Avoiding temperature excursions of any length becomes essential, which means closer monitoring and multiple layers of validated packaging and thermal protection are used in biopharma logistics.

Key Components of Biotech Logistics Programs

The biotech logistics network requires additional rigor around temperature control and security. The basic path to delivery remains the same: arranging storage and transportation, executing the shipment, and providing visibility throughout.

Ultra-Cold and Cryogenic Shipping for Cell and Gene Therapies

The traditional cold chain isn't cold enough for many cell and gene therapies in transport. Distributors need vehicles and transport containers capable of keeping these fragile products at extremely cold temperatures.

The required temperature depends on each product's stability requirements, but most biopharma shipments fall into one of four ranges:

• Refrigerated, 2°C to 8°C: insulin, many vaccines, and most monoclonal antibodies.
• Frozen, about -25°C to -10°C: some mRNA vaccines and biologics.
• Ultra-cold, about -90°C to -60°C: certain mRNA vaccines and other biologics.
• Cryogenic, -150°C or colder: many cell therapies and some gene therapies, typically shipped in liquid nitrogen dry vapor shippers.

Validated Packaging, Couriers, and Direct-to-Patient Delivery

Preparing a shipment for delivery and maintaining a closely documented chain of custody add additional complexity to biopharma logistics. Because temperature control is critical, manufacturers and distributors use validated packaging to transport biotech products. Validated packaging has undergone rigorous testing to confirm it can maintain specified temperature ranges and protect medications from physical damage during transit.

Additional training is necessary to ensure pharma products are shipped safely, which means manufacturers may hire specialty pharma couriers to transport biotech freight. Established chain-of-custody processes, trained drivers, and access to ultra-cold and cryogenic storage make these specialty couriers a strong choice for pharmaceutical companies.

Chain of Custody and Patient Identification for Personalized Medicine

Many cryogenic shipments contain personalized therapies, making chain of custody another key component of biopharma logistics. Some of these treatments, such as autologous cell therapies, are made from a specific patient's own cells and have no therapeutic value for anyone else. In addition, delivering the wrong cell therapy to the wrong person can cause serious patient harm.

Delivering the right personalized medication to the right patient requires maintaining a digital audit trail showing handoffs, arrival times, and locations. Alongside this, biopharma logistics providers maintain a chain of identity, a process that continuously verifies that a specific treatment is matched to its intended patient.

The receiving facility adds its own records to that trail. Digital driver check-in time-stamps each arrival and ties it to the scheduled appointment, so the dock-side handoff is documented, too.

How Do Biotech Startups Build Logistics Programs From Scratch?

Biotech startups typically build logistics programs by moving from small-scale research shipping to a full transportation network as their therapies gain approval. Manufacturers of biologics and personalized medicine often start as researchers developing new treatments in small facilities. Once a treatment shows clinical success, they must transition into large-scale production. Biotech startups in the expansion phase must also build a transportation network capable of delivering their therapies to hospitals across the country and around the world, a transition our guide to top pharma logistics solutions for biotech walks through in more detail.

Choosing the Right 3PL Partner Early

Selecting a 3PL that provides biopharma logistics solutions for startups eases the growing pains of scaling up, one of the criteria covered in our guide on how to evaluate pharma logistics vendors. The right partner provides scaling transport and a reliable ultra-cold chain network. Biotech startups can work with one provider from the early days of small-scale biotech and pharma logistics through full commercial launch and long-term growth.

Scaling From Clinical Trials to Commercial Launch

An experienced biopharma logistics provider can also help develop the transportation network the startup will use to reach hospitals and patients. The provider can adjust the distribution process as the biotech grows into an established company, taking on shipments with tighter deadlines and handling increasing volume.

With an established 3PL partner, biotechs gain access to existing cold storage warehousing, freight relationships, and transportation and dock management systems that help maintain both the ultra-cold chain and chain of custody. Those systems scale with the partner's network. SnoTemp moved dock scheduling for three facilities off spreadsheets and onto Opendock, using its API to sync appointments with its warehouse management system in real time.

Building a Biotech Logistics Program? Start With the Dock.

Scaling up a biotech transportation network requires clear visibility into shipments as they arrive at the dock. Knowing arrival times, dwell times, and chain-of-custody details helps reduce the risk of expensive and patient-harming losses. Opendock helps managers and operators safeguard these valuable shipments with digital appointment scheduling, real-time visibility into every arrival and departure, driver verification at the gate, and time-stamped records that document chain of custody from check-in to check-out.

Frequently Asked Questions

What's the Difference Between Pharma and Biotech Logistics?

Pharma logistics maintains the cold chain and chain of custody for medications and vaccines that typically ship at controlled room or refrigerated temperatures. Biotech logistics takes cold storage and chain of custody a step further, as many biologics and cell or gene therapies require frozen, ultra-cold, or cryogenic temperatures, and some are personalized to a specific patient.

How Do You Ship Cell and Gene Therapies?

Many cell and gene therapies ship in cryogenic containers, often liquid nitrogen dry vapor shippers, that hold -150°C or colder throughout transit. These biotech treatments are continuously monitored for temperature and location as part of the chain-of-custody process. Shippers, manufacturers, and hospital providers also follow a chain-of-identity process to ensure that personalized medications reach the right patient.

What Should a Biotech Startup Look for in a Logistics Partner?

An experienced biopharma logistics provider is well suited to partner with startups entering the launch phase. These 3PLs should have an established process for handling ultra-cold and cryogenic shipments, use real-time monitoring software, and consistently maintain the chain of custody.